BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Tumor necrosis factor-α converting enzyme (TACE) increases RANKL expression in osteoblasts and serves as a potential biomarker of periodontitis

  • Lee, Ji-Hyun (Department of Biochemistry, School of Dentistry, Kyungpook National University) ;
  • Choi, Young-Jin (Department of Biochemistry, School of Dentistry, Kyungpook National University) ;
  • Heo, Sun-Hee (Department of Biochemistry, School of Dentistry, Kyungpook National University) ;
  • Lee, Jae-Mok (Department of Periodontology, School of Dentistry, Kyungpook National University) ;
  • Cho, Je-Yoel (Department of Biochemistry, School of Dentistry, Kyungpook National University)
  • Received : 2011.04.25
  • Accepted : 2011.05.24
  • Published : 2011.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

Periodontitis is a very prevalent disease. Therefore, biomarkers for the early and standard diagnoses of periodontitis are urgently needed. TACE is a membrane-bound metalloprotease. Although a recent study suggested that TACE levels in GCF are elevated during periodontal disease, the levels of TACE in GCF at different stages of chronic periodontitis have not been determined. Here, we analyzed the protein levels of TACE in GCF from periodontal disease subjects and confirmed that the protein levels of TACE were higher in the moderate periodontitis groups. TACE is known to be a NF-${\kappa}B$ ligand that stimulates RANKL secretion in osteoblasts. To understand the effects of TACE on RANKL and OPG in osteoblasts, we treated MG63 cells with TACE. We observed an increase in RANKL protein expression but a decrease in OPG protein expression. Our data suggest that TACE can induce RANKL expression and promote osteoclastogenesis, thus worsening the outcome of periodontitis.

Keywords

References

  1. Listgarten, M. A. (1986) Pathogenesis of periodontitis. J. Clin. Periodontol. 13, 418-430. https://doi.org/10.1111/j.1600-051X.1986.tb01485.x
  2. Mezyk-Kopec, R., Bzowska, M., Potempa, J., Bzowska, M., Jura, N., Sroka, A., Black, R. A. and Bereta, J. (2005) Inactivation of membrane tumor necrosis factor alpha by gingipains from Porphyromonas gingivalis. Infect. Immun. 73, 1506-1514. https://doi.org/10.1128/IAI.73.3.1506-1514.2005
  3. Sorsa, T., Suomalainen, K. and Uitto, V. J. (1990) The role of gingival crevicular fluid and salivary interstitial collagenases in human periodontal diseases. Arch. Oral Biol. 35 (Suppl), S193-196. https://doi.org/10.1016/0003-9969(90)90156-5
  4. Primakoff, P. and Myles, D. G. (2000) The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet. 16, 83-87. https://doi.org/10.1016/S0168-9525(99)01926-5
  5. Bostanci, N., Emingil, G., Afacan, B., Han, B., Ilgenli, T., Atilla, G., Hughes, F. J. and Belibasakis, G. N. (2008) Tumor necrosis factor-alpha-converting enzyme (TACE) levels in periodontal diseases. J. Dent. Res. 87, 273-277. https://doi.org/10.1177/154405910808700311
  6. Schoppet, M., Preissner, K. T. and Hofbauer, L. C. (2002) RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function. Arterioscler. Thromb. Vasc. Biol. 22, 549-553. https://doi.org/10.1161/01.ATV.0000012303.37971.DA
  7. Krajewski, A. C., Biessei, J., Kunze, M., Maersch, S., Perabo, L. and Noack, M. J. (2009) Influence of lipopolysaccharide and interleukin-6 on RANKL and OPG expression and release in human periodontal ligament cells. Apmis. 117, 746-754. https://doi.org/10.1111/j.1600-0463.2009.02532.x
  8. Bostanci, N., Ilgenli, T., Emingil, G., Afacan, B., Han, B., Toz, H., Atilla, G., Hughes, F. J. and Belibasakis, G. N. (2007) Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio. J. Clin. Periodontol. 34, 370-376. https://doi.org/10.1111/j.1600-051X.2007.01061.x
  9. Belibasakis, G. N., Meier, A., Guggenheim, B. and Bostanci, N. (2011) Oral biofilm challenge regulates the RANKL-OPG system in periodontal ligament and dental pulp cells. Microb. Pathog. 50, 6-11. https://doi.org/10.1016/j.micpath.2010.11.002
  10. Bostanci, N., Reddi, D., Rangarajan, M., Curtis, M. A. and Belibasakis, G. N. (2009) Porphyromonas gingivalis stimulates TACE production by T cells. J. Oral Microbiol. 24, 146-151. https://doi.org/10.1111/j.1399-302X.2008.00488.x
  11. Lum, L., Wong, B. R., Josien, R., Becherer, J. D., Erdjument-Bromage, H., Schlondorff, J., Tempst, P., Choi, Y. and Blobel, C. P. (1999) Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J. Biol. Chem. 274, 13613-13618. https://doi.org/10.1074/jbc.274.19.13613
  12. Pan, B., Farrugia, A. N., To, L. B., Findlay, D. M., Green, J., Lynch, K. and Zannettino, A. C. (2004) The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE). J. Bone. Miner. Res. 19, 147-154. https://doi.org/10.1359/jbmr.2004.19.1.147
  13. Brechter, A. B., Persson, E., Lundgren, I. and Lerner, U. H. (2008) Kinin B1 and B2 receptor expression in osteoblasts and fibroblasts is enhanced by interleukin-1 and tumour necrosis factor-alpha. Effects dependent on activation of NF-kappaB and MAP kinases. Bone 43, 72-83. https://doi.org/10.1016/j.bone.2008.02.003
  14. Franchimont, N., Lambert, C., Huynen, P., Ribbens, C., Relic, B., Chariot, A., Bours, V., Piette, J., Merville, M. P. and Malaise, M. (2005) Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells. Arthritis Rheum. 52, 84-93. https://doi.org/10.1002/art.20727
  15. Lee, J. H., Kim, B. G., Ahn, J. M., Park, H. J., Park, S. K., Yoo, J. S., Yates, J. R., 3rd and Cho, J. Y. (2010) Role of PI3K on the regulation of BMP2-induced beta-Catenin activation in human bone marrow stem cells. Bone 46, 1522-1532. https://doi.org/10.1016/j.bone.2010.02.013
  16. Lau, Y. S., Adamopoulos, I. E., Sabokbar, A., Giele, H., Gibbons, C. L. and Athanasou, N. A. (2007) Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma. Br. J. Cancer 96, 1716-1722. https://doi.org/10.1038/sj.bjc.6603774

Cited by

  1. Sclerostin serum levels in prostate cancer patients and their relationship with sex steroids vol.25, pp.2, 2014, https://doi.org/10.1007/s00198-013-2462-y
  2. The RANKL-OPG system in clinical periodontology vol.39, pp.3, 2012, https://doi.org/10.1111/j.1600-051X.2011.01810.x
  3. Gene and protein localisation of tumour necrosis factor (TNF)-α converting enzyme in gingival tissues from periodontitis patients with drug-induced gingival overgrowth vol.58, pp.8, 2013, https://doi.org/10.1016/j.archoralbio.2013.02.011
  4. Periodontal disease and gene-expression levels of metalloendopeptidases in human buccal mucosal epithelium vol.48, pp.5, 2013, https://doi.org/10.1111/jre.12045
  5. Comparisons between two biochemical markers in evaluating periodontal disease severity: a cross-sectional study vol.14, pp.1, 2014, https://doi.org/10.1186/1472-6831-14-107
  6. Soluble RANKL Cleaved from Activated Lymphocytes by TNF-α–Converting Enzyme Contributes to Osteoclastogenesis in Periodontitis vol.197, pp.10, 2016, https://doi.org/10.4049/jimmunol.1601114